Wachovia downgrades Alexion Pharmaceuticals (Nasdaq: ALXN) from Outperform to Market Perform, with a $69-$77 valuation range.

The firm said ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE